Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants

Am J Transplant. 2022 Jul;22(7):1925-1926. doi: 10.1111/ajt.16955. Epub 2022 Jan 19.

Affiliations

¹ Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA.
² Department of Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
³ Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
⁴ Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

PMID: 35015924
DOI: 10.1111/ajt.16955

No abstract available

Publication types

Letter

MeSH terms

Drug Interactions
HIV Infections* / drug therapy
Humans
Immunosuppression Therapy
Immunosuppressive Agents / therapeutic use
Ritonavir*

Substances

Immunosuppressive Agents
Ritonavir